Tilavonemab
Modify Date: 2024-04-02 18:48:21
Tilavonemab structure
|
Common Name | Tilavonemab | ||
|---|---|---|---|---|
| CAS Number | 2096513-89-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TilavonemabTilavonemab (ABBV-8E12) is a humanised anti-tau antibody that binds amino acids 25-30 near the N-terminal end of the tau protein. Tilavonemab blocks the ability of human and mouse neurons to take up tau aggregates and reduces brain atrophy. Tilavonemab can be used in the study of Alzheimer's disease[1]. |
| Name | Tilavonemab |
|---|
| Description | Tilavonemab (ABBV-8E12) is a humanised anti-tau antibody that binds amino acids 25-30 near the N-terminal end of the tau protein. Tilavonemab blocks the ability of human and mouse neurons to take up tau aggregates and reduces brain atrophy. Tilavonemab can be used in the study of Alzheimer's disease[1]. |
|---|---|
| Related Catalog | |
| Target |
tau[1]. |
| References |
| No Any Chemical & Physical Properties |